KR20010069167A - Embryo from wild animal with inter-species nuclear transplantation and method for production thereof - Google Patents

Embryo from wild animal with inter-species nuclear transplantation and method for production thereof Download PDF

Info

Publication number
KR20010069167A
KR20010069167A KR1020000004381A KR20000004381A KR20010069167A KR 20010069167 A KR20010069167 A KR 20010069167A KR 1020000004381 A KR1020000004381 A KR 1020000004381A KR 20000004381 A KR20000004381 A KR 20000004381A KR 20010069167 A KR20010069167 A KR 20010069167A
Authority
KR
South Korea
Prior art keywords
cell
pipette
eggs
tiger
oocyte
Prior art date
Application number
KR1020000004381A
Other languages
Korean (ko)
Inventor
황우석
이병천
박종임
용환율
조종기
김기연
신수정
안국준
현상환
노상호
임정묵
Original Assignee
황우석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 황우석 filed Critical 황우석
Priority to KR1020000004381A priority Critical patent/KR20010069167A/en
Priority to EP00941006A priority patent/EP1117763A4/en
Priority to JP2001506788A priority patent/JP2003503045A/en
Priority to RU2000132214/13A priority patent/RU2205537C2/en
Priority to PCT/KR2000/000706 priority patent/WO2001000794A1/en
Priority to CN 00800651 priority patent/CN1304445A/en
Priority to NZ508739A priority patent/NZ508739A/en
Priority to CA002334954A priority patent/CA2334954A1/en
Priority to AU55777/00A priority patent/AU753209B2/en
Publication of KR20010069167A publication Critical patent/KR20010069167A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8776Primate embryos

Abstract

PURPOSE: A nuclear transplantation method between different species and a method for producing somatic cell cloned oocyte of wild animal are provided. The method can be applied to various other mammal animals including human. CONSTITUTION: The method for producing somatic cell cloned oocyte of wild animal comprises the steps of: collecting an immatured oocyte from a cow and incubating it; separating cell lines from various tissue of a tiger; cutting the transparent membrane of the matured oocyte and removing fist polar body and 10 to 30% of cytoplasm; transplanting the cell lines as a donor into the nucleus removed oocyte; adding the DC electric shock into the transplanted oocyte to produce the fusion cell; activating the fusion cell in a medium containing chemical materials immediately after electric shock; and second activating and incubating the fusion cell in a drop medium.

Description

이종간 핵이식 방법 및 그를 이용한 야생동물 복제 수정란과 그 생산 방법{Embryo from wild animal with inter-species nuclear transplantation and method for production thereof }Embryo from wild animal with inter-species nuclear transplantation and method for production

본 발명은 야생동물의 복제 수정란 생산 방법에 관한 것으로서, 보다 상세히는 핵이식 기술을 통해 소 유래 미성숙 난자를 채취, 탈핵하고 여기에 야생동물 조직으로 부터 분리한 체세포의 핵을 이식함으로써 체세포 복제에 의한 야생동물의 복제 수정란의 생산 방법을 제공하는데 있다. 본 발명의 한 바람직한 실시예에 따르면 호랑이 귀 조직으로부터 분리한 체세포의 핵을 소 유래 수핵난자에 이식하여 생산된 호랑이의 임신가능한 복제수정란이 제공된다.The present invention relates to a method for producing cloned fertilized eggs in wild animals, and more particularly, by somatic cloning by collecting and denuclearizing immature eggs derived from bovine through nuclear transplantation technology and transplanting nuclei of somatic cells isolated from wild animal tissue. To provide a method for producing cloned fertilized eggs of wild animals. According to one preferred embodiment of the present invention there is provided a gestational cloned embryo of a tiger produced by transplanting the nucleus of somatic cells isolated from tiger ear tissue into a bovine-derived nucleus egg.

본 발명은 소의 난자를 수핵난으로하여 야생동물의 핵과 소의 수핵란과의 이종간 핵이식을 수행함으로써 체세포 복제에 의해 임신 가능한 야생동물의 복제수정란을 생산하는데 그 목적이 있다.An object of the present invention is to produce a cloned fertilized egg of a wild animal that can be conceived by somatic cloning by performing a heterologous nuclear transfer between a nucleus of a wild animal and a nucleus of a bovine egg using a nucleus of a bovine egg.

본 발명에 따르면, 다음과 같은 공정단계들로 구성되는 호랑이의 복제수정란 생산 방법이 제공된다:According to the present invention, there is provided a method for producing a cloned fertilized egg of a tiger, which consists of the following process steps:

(a) 도축난소로부터 미성숙난자를 채취 배양하는 단계;(a) harvesting immature eggs from slaughtered ovaries;

(b) 호랑이의 신체조직을 채취, 세포주를 분리하는 단계;(b) harvesting the body tissue of the tiger, separating the cell line;

(c) 상기 (a)단계에서 준비된 성숙난자의 투명대 일부를 절개하고 세포질의 10∼30%를 제거하여 탈핵을 실시하는 단계;(c) dissecting a portion of the zona pellucida of the mature egg prepared in step (a) and denuclearizing by removing 10-30% of the cytoplasm;

(d) 상기 (b)단계에서 준비된 공여세포를 상기 (c)단계의 탈핵된 난자에 이식하는 단계;(d) transplanting the donor cells prepared in step (b) into denucleated eggs of step (c);

(e) 상기 (d)단계에서 이식 및 밀착시킨 작성란을 DC 조건의 전압으로 전기융합시키는 단계;(e) electrically fusion of the embryonated eggs implanted and adhered in step (d) to a voltage under DC conditions;

(f) 상기 융합된 세포를 융합과 동시에 또는 화학물질이 첨가된 배지내에서 활성화시키는 단계; 및(f) activating the fused cells concurrently with fusion or in a medium to which chemicals have been added; And

(g) 상기 활성화된 세포를 후활성화 및 미소적 배지내에서 배양시키는 단계.(g) culturing the activated cells in post-activation and micromedia.

본 발명의 한 실시예에 따르면, 상기 (b) 단계의 세포는 호랑이의 귀로부터 분리된 세포이다.According to one embodiment of the invention, the cell of step (b) is a cell isolated from the tiger's ear.

또한, 상기 (b) 단계의 보존처리는 계대배양, 혈청기아배양 또는 동결보존에 의해 이루어질 수 있다.In addition, the preservation of the step (b) can be made by subculture, serum starvation or cryopreservation.

이하에서는 본 발명 방법에 따라 수행된 바람직한 실시예 및 실험예를 구체적으로 기재한다.Hereinafter, the preferred examples and experimental examples performed according to the method of the present invention will be described in detail.

실시예 1 : 핵이식Example 1 Nuclear Transplantation

핵 이식준비 과정은 다음과 같이 수행하였다.The nuclear transfer preparation process was performed as follows.

제1단계 : Micro 피펫의 준비Step 1: Preparation of the Micro Pipette

Micro피펫을 준비함에 있어서 사용기기는,In preparing the micro pipette,

Puller(Narishige PC-10), Microforge(Narishige MF-9), Glinder(Narishige EG-4) 등이다.Puller (Narishige PC-10), Microforge (Narishige MF-9), Glinder (Narishige EG-4).

우선, 절개 및 탈핵용 피펫(cutting & Enucleation 피펫) 제조를 위해, 유리관(Drummond; Sigma, P-2174 or narishige)을 사용하여 추(Light 1개와 heavy 1개 또는 light 2개, heavy 1개)를 부착하고 Pulling step으로 Step 2에 고정한 다음, 온도(heat 1 : 101℃, heat 2 : 101.5℃)를 조정한다.First, in order to manufacture incision and denuclearization pipettes, a weight (1 light, 1 heavy or 2 light, 1 heavy) was used using a glass tube (Drummond; Sigma, P-2174 or narishige). After attaching and fixing to Step 2 with a pulling step, adjust the temperature (heat 1: 101 ℃, heat 2: 101.5 ℃).

두번째로, 공여핵세포 이식용 피펫(Injection pipette, 내경 30∼40㎛) 제조를 위해 유리관(Drummond; Sigma, P-2174 or narishige)을 사용하여 추(Light 1개) 또는 추를 제거하고 Pulling step으로 Step 2에 고정한 다음 온도를(heat 1 : 101℃, heat 2 : 101.5℃) 조정한다.Second, remove the weight (1 light) or weight using a glass tube (Drummond; Sigma, P-2174 or narishige) for the manufacture of injection pipettes (Injection pipette, internal diameter 30-40 ㎛) Fix in Step 2 and adjust the temperature (heat 1: 101 ℃, heat 2: 101.5 ℃).

다음에, 고정용 피펫(Holding pipette, 내경 70∼130㎛) 제조(2가지)를 위해 다음과 같이 수행하였다.Next, to prepare a holding pipette (Holding pipette, inner diameter 70 ~ 130㎛) (two) was carried out as follows.

i) 유리관(Drummond; Sigma, P-2174)을 사용하는 경우 :i) When using glass tubes (Drummond; Sigma, P-2174):

추(Light 1개 ∼light 2개, heavy 1개)를 부착하고 Pulling step(Step 1)에 고정한 다음 온도(heat 2 : 101.5℃)를 조정한다.Attach the weight (1 light ~ 2 light, 1 heavy), fix it to the pulling step (Step 1), and adjust the temperature (heat 2: 101.5 ℃).

ii) 유리관(Narishige G-1 or GD-1)을 사용하는 경우ii) When using glass tubes (Narishige G-1 or GD-1)

추(Light 1개, heavy 1개)를 부착하고 Pulling step(Step 1)에 고정한 다음, 온도(heat 2 : 101.5℃)를 조정한다.Attach the weight (1 light, 1 heavy), fix it to the pulling step (Step 1), and adjust the temperature (heat 2: 101.5 ℃).

넷째로, 난자의 세정 및 운반용 피펫 제조를 위해Fourthly, for the manufacture of pipettes for cleaning and transporting eggs

알코올 램프를 이용하여 내경이 300㎛ 이상이 되도록 하고, 사용시 한번 이용한 것은 폐기하였다.The alcohol lamp was used to have an inner diameter of 300 µm or more, and once used, it was discarded.

다섯째로, 난구세포제거(Denuding용)용 피펫 제조를 위해Fifth, for the manufacture of pipettes for removal of cumulus cells (for denuding)

알코올램프를 이용하여 내경이 약 130㎛인 것을 여러개 만들어 준비하였다.An alcohol lamp was used to prepare a plurality of inner diameters of about 130 μm.

제2단계 : 배양액의 조제Second Step: Preparation of Culture Solution

배양액(medium)은 다음과 같이 준비하였다.Culture medium was prepared as follows.

IVM용 TCM-199으로 체외수정과 동일하게 제조하고, TCM-W으로, 사용 당일에는 작업용 미소적을 작성하되 9ml의 TCM-W에 1ml의 FBS(FCS)를 넣어 10%FBS TCM-W를 만든 후, 필요한 점적 수만큼 100㎕ 피펫을 이용하여 20∼30㎕ 점적을 적정한 크기(35mm, 60mm, 100mm등)의 디쉬에 만들고, 미네랄 오일로 도포한 다음 사용한다.TCM-199 for IVM is manufactured in the same way as in vitro fertilization, and on the day of use with TCM-W, a small amount for work is prepared, but 1ml of FBS (FCS) is added to 9ml of TCM-W to make 10% FBS TCM-W. Using a 100µl pipette, use 20µl droplets in a suitable size (35mm, 60mm, 100mm, etc.) dish, apply with mineral oil, and use.

또, 하이알루로니데이즈(Sigma, H-3506) solution을 제조하기 위해서는, 5ml의 TCM-W에 하이알루로니데이즈(Hyaluronidase) 0.0500g을 첨가하여 원액(stock)을만들었다. 만들어진 원액은 111㎕씩 eppendorf 시험관에 분주하여 냉동실에 보관하였다. 사용시에는 TCM-W를 1ml 분주하여 최종농도를 0.1%로 맞추어 35mm 디쉬에 분주하여 난구세포제거(denuding)에 이용한다.In addition, in order to prepare a hyaluronidase (Sigma, H-3506) solution, 5ml of TCM-W was added to 0.0500g of hyaluronidase (Hyaluronidase) to make a stock (stock). The prepared stock solution was dispensed into eppendorf test tubes by 111 μl and stored in the freezer. In use, 1 ml of TCM-W is dispensed and the final concentration is adjusted to 0.1% and dispensed into 35 mm dishes for dendritic cell removal.

그리고, Cytochalasin B(sigma, C-6762) solution 제조를 위해,And, for the preparation of Cytochalasin B (sigma, C-6762) solution,

DMSO(Sigma, D-5879) 133㎕에 1mg의 사이토칼라신 B(cytochalasin B)를 녹이면 농도는 7.5mg/ml이 되는데, 이것을 eppendorf 시험관에 1㎕씩 분주해서 냉동실에 보관한다. 사용할때는 여기에 10% FBS(또는 FCS)첨가 TCM-W를 1ml 첨가하여 절개 및 탈핵(cutting & enucleation) 미소적 제작에 이용한다.After dissolving 1 mg of cytocalasin B in 133 μl of DMSO (Sigma, D-5879), the concentration is 7.5 mg / ml. Dispense 1 μl into eppendorf test tubes and store in the freezer. In use, 1 ml of 10% FBS (or FCS) -added TCM-W is added and used for microscopic cutting and enucleation.

또한, PHA-P(Phytohematoglutinin: L-9132) solution 제조법은 5mg의 PHA를 10ml의 TCM-W와 섞은 후 100㎕씩 eppendorf 시험관에 분주한 다음, 실험에 사용할 경우 eppendorf 시험관에 400㎕의 TCM-W를 첨가하여 작업용 미소적을 만들어 사용한다. 이때 최종 농도는 100㎍/ml이 되도록 한다.In addition, PHA-P (Phytohematoglutinin: L-9132) solution is prepared by mixing 5 mg of PHA with 10 ml of TCM-W and dispensing 100 μl into eppendorf test tubes, and then 400 μl of TCM-W into eppendorf test tubes when used in the experiment. Use it to make working microdroplets by adding. At this time, the final concentration is to be 100 ㎍ / ml.

그리고, 전기융합 및 활성화 배지(Electrofusion and Activation media) 제조를 위해서는 Mole 농도에 따른 만니톨(Sigma, M-1902)의 첨가량 (100ml기준)을 0.28M 만니톨: 5.1016g; 0.25M 만니톨: 4.555g; 0.26M 만니톨: 4.7372g; 0.1mM MgSO4, 0.1mM CaCl2포함하고, 기타 첨가물(만니톨 mole 농도에 관계없음): 0.1mM MgSO4또는 MgCl2, 0.1mM CaCl2(융합과 활성 동시군에서 첨가); Hepes 0.5mM; BSA 0.05%을 첨가하되 DW를 100ml까지 첨가한다.And, in order to prepare the electrofusion and activation media (Electrofusion and Activation media) the amount of mannitol (Sigma, M-1902) added according to the Mole concentration (100ml standard) 0.28M mannitol: 5.1016g; 0.25 M mannitol: 4.555 g; 0.26 M mannitol: 4.7372 g; 0.1 mM MgSO 4 , 0.1 mM CaCl 2 , other additives (regardless of mannitol mole concentration): 0.1 mM MgSO 4 or MgCl 2 , 0.1 mM CaCl 2 (added in the fusion and active co-group); Hepes 0.5 mM; Add 0.05% BSA but add up to 100 ml DW.

pH를 7.2∼7.4로 맞추고, 5ml 시험관에 약 4ml씩 분주하여 냉동(장기간) 혹은 냉장실(단기)에 보관한다.Adjust the pH to 7.2-7.4, dispense about 4ml into 5ml test tube and store in freezer (long-term) or freezer (short-term).

한편, DMAP(Sigma, D-2629)제조법은 10ml IVC용액에 0.0031g DMAP을 첨가하여 용해 및 여과후(0.22㎛ filter 사용) eppendort 시험관에 분주시키고 냉동보관(1.9mM)한다.On the other hand, in the manufacturing method of DMAP (Sigma, D-2629), 0.0031 g DMAP is added to a 10 ml IVC solution, dissolved and filtered (using a 0.22 μm filter), and then dispensed into a eppendort test tube and frozen (1.9 mM).

또, Cycloheximide(Sigma, C-7698)는, Ethanol 100ml에 Cycloheximide 1g을 녹여 ×1000배 Stock을 작성 최종농도10㎍/㎖가 되도록 IVC medium에 첨가하여 사용한다.Cycloheximide (Sigma, C-7698) is prepared by dissolving 1 g of Cycloheximide in 100 ml of ethanol and adding a 1000 × stock to the IVC medium to a final concentration of 10 µg / ml.

그리고, Ionomycin(Sigma, I-0634)은, DMSO(Sigma, D-5879) 1.34ml에 1mg의 Ionomycin을 녹여 1mM 원액을 제조한 다음, 최종농도 5㎛이 되도록 1% BSA TCM-W 또는 IVC medium내에 첨가하여 사용하고 원액을 냉동보관한다.In addition, Ionomycin (Sigma, I-0634) is dissolved in 1mg of Ionomycin in 1.34ml of DMSO (Sigma, D-5879) to prepare a 1mM stock solution, and then 1% BSA TCM-W or IVC medium to a final concentration of 5㎛ It is added and used in the container, and the stock solution is kept frozen.

Ca2+Ionophore(A23187)는, DMSO(Sigma, D-5879) 1.66ml에 1mg의 Ca2+Ionophore(A23187)를 녹여 1mM 원액 제조시 최종농도 5㎛가 되도록 1% BSA, TCM-W 또는 IVC medium내에 첨가하여 사용하고 원액을 냉동보관한다.Ca 2+ Ionophore (A23187) is dissolved in 1 mg of Ca 2+ Ionophore (A23187) in 1.66 ml of DMSO (Sigma, D-5879), so that 1% BSA, TCM-W or IVC is used to prepare a final concentration of 5 μm. Add to medium and store the stock solution for freezing.

배양액(culture Medium)은 CR2aa를 사용하고(No. 2), Hoechst 33342 (Sigma, B-2261)는 25mg의 Hoechst에 증류수를 5ml 섞어 희석(5mg/ml 의 stock)시킨 다음, Stock 1∼2㎕씩 eppendorf 시험관에 분주, 냉동보관한다. 그리고, 사용시에는 시험관에 10% FBS 첨가하고 TCM-W를 1ml 첨가하여 희석시킨 후 사용(최종농도 5∼10㎍/ml)한다.For culture medium, CR2aa was used (No. 2), and Hoechst 33342 (Sigma, B-2261) was diluted with 5 ml of distilled water (25 mg / ml stock) in 25 mg of Hoechst, and then 1 to 2 µl of stock. Dispense and freeze into eppendorf test tubes. In addition, 10% FBS is added to a test tube, 1 ml of TCM-W is diluted, and it is used after use, and it uses (final concentration 5-10microgram / ml).

10∼15분간 정치한 다음 암실, 형광현미경으로 탈핵여부를 판단할 수 있다.After standing for 10-15 minutes, denuclearization can be determined using a dark room or a fluorescence microscope.

Nocodazole stock (Sigma, M-1404)은, DMSO(Sigma, D-5879) 2.5ml를 10mg의 nocodazole병에 넣어 희석시킨 다음 50∼100㎕씩 eppendorf 시험관에 분주(4mg/ml의 stock)하고 Stock 1㎕를 원하는 배양액 10ml에 첨가(0.4㎍/m)한다.Nocodazole stock (Sigma, M-1404) was diluted in 2.5 ml of DMSO (Sigma, D-5879) in a 10 mg nocodazole bottle, and then divided into 50 to 100 μl in eppendorf test tubes (4 mg / ml stock). [Mu] l is added (0.4 [mu] g / m) to 10 ml of the desired culture.

Acid Tyrode's(Sigma, T-1788) 제조법은 Embryo tested된 완제품으로 미소적(25㎕)을 만들어 오일도포 후 사용한다.Acid Tyrode's (Sigma, T-1788) manufacturing method is Embryo-tested finished product (25µl) is used after oil coating.

제3단계 : 미분간섭 현미경 작업용 디쉬 제작Step 3: preparing a dish for undifferentiated microscope work

미분간섭(Differential Interference Contrast, DIC)현미경 작업용 디쉬는 다음과 같이 제작하였다.Differential Interference Contrast (DIC) microscope work dishes were prepared as follows.

50mm 디쉬(Falcon 1006) 뚜껑에 직경 1∼3cm로 천공한 다음 Silicon (ShinEtsu KE45)을 디쉬 내부의 구멍주위에 도포한 후, 가로×세로 크기가 2∼4cm의 커버글라스를 실리콘위에 놓고 눌러서 부착시킨다.Perforate the 50mm dish (Falcon 1006) with a diameter of 1 ~ 3cm, apply Silicon (ShinEtsu KE45) around the hole inside the dish, and attach the cover glass of 2 × 4cm in width x length on the silicone .

끝으로, 알코올로 세정한다.Finally, rinse with alcohol.

제4단계 : DIC 현미경용 미소적 제작Step 4: Microfabrication for DIC Microscope

DIC 현미경용 미소적 제작법은 다음과 같이 제작하였다.The microfabrication method for a DIC microscope was produced as follows.

DIC용 작업용 디쉬의 커버글라스 위에 20㎕ 피펫을 이용하여 5∼10㎕ 미소적을 세로로 분주한 다음(미소적의 개수는 난자 20∼30개당 1개씩 계산) 1㎖ 피펫을 이용하여 4㎖정도의 미네랄 오일(sigma, M-3516)을 미소적 주위에 도포한다. 이때, 각 과정에 적합한 배지로 미소적을 형성시킨다.Dispense 5-10 μl micro dropwise vertically using a 20 μl pipette on the cover glass of the DIC working dish (the number of micro drop counts 1 per 20-30 eggs) and then use a 1 ml pipette Oil (sigma, M-3516) is applied around the microspheres. At this time, microdrops are formed with a medium suitable for each process.

제5단계 : 공여핵원용 체세포 준비Step 5: Prepare Somatic Cells for Donor Nuclei

공여핵원용 체세포(Somatic cell line for donor)의 준비는 다음과 같이 수행하였다.Somatic cell line for donor preparation was performed as follows.

세포주는 호랑이 조직(Tissue)에서 분리하였다(다음 실험예 참조).Cell lines were isolated from tiger tissue (see Tissue).

실험예 1 : 귀(ear)에서의 세포 분리Experimental Example 1 Cell Separation from Ear

성체 또는 어린 동물의 귀 선단에서 떼어낼 부위 주변의 체모를 깎고, 소독용 알코올과 베타딘으로 소독한다. 멸균된 기구로 1∼2cm2넓이의 피부 조직을 절제한 다음, 50 ml 시험관에 PBS용액을 준비하여 절제된 조직을 넣어 4℃로 냉장 보관하여 실험실로 운반한다.Shave the hair around the area to be removed from the ear tip of an adult or young animal and disinfect with rubbing alcohol and betadine. After dissecting 1 ~ 2cm 2 of skin tissue with a sterile instrument, prepare PBS solution in 50 ml test tube, put the excised tissue and store it at 4 ° C and transport it to the laboratory.

다시 PBS 용액으로 세정한 다음, 멸균된 집게로 고정한 후, 체모를 포함한 피부와 연골조직을 멸균된 가위, 날(blade)로 분리하여, 연골조직과 면한 피부 내측의 조직을 채취한다.After washing with PBS solution again, and fixed with sterile forceps, skin and cartilage tissue, including body hair, are separated by sterile scissors and blades, and tissues inside the skin facing the cartilage tissue are collected.

조직편을 다시 PBS 용액으로 세정 후 칼날(blade)로 세절한 다음, 0.25% 트립신, 1mM EDTA 용액과 0.8% 콜라게나제형(Collagenase type III) II(GIBCO BRL, Life Technologies, USA) 용액의 혼합액을 첨가하여 39℃, 5% CO2의 포화습도 배양기내에서 배양한다.The tissue piece was washed again with PBS solution, and then cut into blades, and a mixture of 0.25% trypsin, 1 mM EDTA solution and 0.8% Collagenase type II (GIBCO BRL, Life Technologies, USA) solution was added. Incubated in a saturated humidity incubator at 39 ° C. and 5% CO 2 .

정치 후 원심 분리용 시험관에 옮겨 와동(vortexing)과 피펫작업(pipetting) 후, PBS 용액을 첨가하여 같은 조건으로 원심세정한다.After standing, it is transferred to a centrifuge test tube, and after vortexing and pipetting, PBS solution is added and centrifuged under the same conditions.

최종 원심세정 후, 침전 세포를 10% FCS, 1% 비필수 아미노산 용액, P/S 첨가 DMEM(Dulbecco's Modified Eagles medium, GIBCO BRL, Life Technologies, USA)에 부유시킨 후, 세포 배양용 페트리디쉬로 옮겨 39℃, 5% CO2의 포화습도 배양기내에서 배양한다.After final centrifugation, the precipitated cells were suspended in 10% FCS, 1% non-essential amino acid solution, P / S added DMEM (Dulbecco's Modified Eagles medium, GIBCO BRL, Life Technologies, USA) and transferred to Petri dishes for cell culture. Incubate in a saturated humidity incubator at 39 ° C., 5% CO 2 .

세포가 배양접시 바닥면에 부착하여 분열 증식하여 단층이 형성되면 이를 1차 세포주의 성립으로 간주한다.When cells adhere to the bottom of the culture plate and divide and proliferate to form a monolayer, this is regarded as the establishment of a primary cell line.

실험예 2 : 계대 배양Experimental Example 2 Passage Culture

단층이 형성된 1차 세포주의 계대배양을 다음과 같이 실시하였다.Subculture of the primary cell line in which the monolayer was formed was performed as follows.

페트리디쉬의 배양액을 버리고, 상기 실험예 1의 0.25% 트립신, 1mM EDTA 용액을 첨가하여 1 내지 2분 정치 후, 배양용 배지로 교체한다.The culture medium of Petri dish was discarded and 0.25% trypsin and 1 mM EDTA solution of Experimental Example 1 were added thereto, and after 1 to 2 minutes, the culture medium was replaced.

피펫팅하여 세포를 배양 배지 중에 재부유시킨 다음 적당량을 새로운 페트리디쉬에 분주한 후, 배지를 첨가하여 39℃, 5% CO2의 포화습도 배양기내에서 배양한다.The cells are resuspended in culture medium by pipetting, then aliquoted into fresh Petri dishes, and then cultured in a 39 ° C., 5% CO 2 saturated humidity incubator.

실험예 3 : 혈청기아(serum starvation) 배양Experimental Example 3 Serum Starvation Culture

상기 실험예 1의 10% FCS 1% 비필수 아미노산 용액, P/S 첨가 DMEM(Dulbecco's Modified Eagles Medium, GIBCO BRL, Life Technologies, USA)에서 배양, 증식중인 세포주를 0.5 % FCS 첨가 배양액으로 교체하고, 3 내지 10일간 배양 후 공여핵원으로 제공하였다.10% FCS 1% non-essential amino acid solution of Experimental Example 1, P / S addition cultured in DMEM (Dulbecco's Modified Eagles Medium, GIBCO BRL, Life Technologies, USA), replacing the proliferating cell line with 0.5% FCS addition culture, After 3 to 10 days of incubation it was provided as a donor nucleus.

실험예 4 : 세포주의 동결보존Experimental Example 4: Cryopreservation of Cell Lines

유착상태의 세포를 상기 실험예와 같은 방법으로 재부유하여 세포 수가 1 X 105/ml로 되도록 조절한 다음, 세포를 포함한 전체 배양액 중에 DMSO(Dimethyl sulfoxide, Sigma, USA)가 10% 농도가 되도록 첨가하여 희석한 후 Cryovial(Corning, USA)에 봉입한다.Resuspend the adherent cells in the same manner as in Experimental Example to adjust the number of cells to 1 X 10 5 / ml, and then to make 10% concentration of DMSO (Dimethyl sulfoxide, Sigma, USA) in the total culture solution containing the cells. After dilution, the solution is enclosed in Cryovial (Corning, USA).

Cryovial을 -70℃ 냉동고에 넣어 18∼24시간 보관한 후 액체 질소 탱크에 넣어 보관한다.Store Cryovial in -70 ℃ freezer for 18-24 hours and store in liquid nitrogen tank.

실험예 5 : 동결보존 세포주의 융해Experimental Example 5: Fusion of cryopreserved cell lines

액체질소 탱크에서 Cryovial 을 꺼내어 37℃ 온수에 넣어 융해시키고, 융해된 세포를 원심 분리용 시험관에 넣고 상기 실험예 1의 PBS를 첨가하여 1,500rpm, 2분간 원심 세정한다. 상층액을 버리고 세포 침전물을 조심스럽게 하여 원심 세정을 2 회 반복한다.Cryovial was removed from the liquid nitrogen tank and fused in hot water at 37 ° C., and the fused cells were placed in a test tube for centrifugation. PBS was added and centrifuged at 1500 rpm for 2 minutes. Discard the supernatant and carefully centrifuge twice with careful cell precipitate.

최종 원심세정 후, 침전 세포를 10% FCS, 1% 비필수 아미노산 용액, P/S 첨가 DMEM(Dulbecco's Modified Eagles medium, GIBCO BRL, Life Technologies, USA)에 부유시킨 후, 세포 배양용 페트리디쉬로 옮겨 39℃, 5% CO2의 포화습도 배양기내에서 배양한다.After final centrifugation, the precipitated cells were suspended in 10% FCS, 1% non-essential amino acid solution, P / S added DMEM (Dulbecco's Modified Eagles medium, GIBCO BRL, Life Technologies, USA) and transferred to Petri dishes for cell culture. Incubate in a saturated humidity incubator at 39 ° C., 5% CO 2 .

실험예 6: 체세포의 핵상관찰(Giemsa Stain 이용)Experimental Example 6: nuclear observation of somatic cells (using Giemsa Stain)

Giemsa stain을 이용하여 체세포의 핵상관찰을 위해 다음 준비물을 사용하였다. 즉, 저장처리용액 (0.9% sodium citrate 용액 또는 0.56% KCL 용액); 고정액 (메탄올 : acetic acid = 3 : 1); 5% Giemsa; 슬라이드 글라스; 15ml 시험관The following preparations were used for nuclear observation of somatic cells using Giemsa stain. That is, a stock solution (0.9% sodium citrate solution or 0.56% KCL solution); Fixative (methanol: acetic acid = 3: 1); 5% Giemsa; Slide glass; 15ml test tube

체세포의 관찰과정으로는,In the process of observing somatic cells,

디쉬내의 세포를 부유시킨 후(Single cell), 15ml 시험관에서 1500rpm으로 2분간 원심분리하여 세포 펠릿(pellet)을 얻는다.After floating the cells in the dish (Single cell), centrifuged for 2 minutes at 1500rpm in a 15ml test tube to obtain a cell pellet (pellet).

다음, 펠릿(pellet)에 저장액을 첨가하고 부유하여 15분간 수화시킨 다음 총 부피의 1/3에 해당하는 고정액을 첨가한다.Next, the stock solution is added to the pellet, suspended, hydrated for 15 minutes, and then a fixed solution corresponding to 1/3 of the total volume is added.

그 후, 원심분리시킨(1500rpm, 2분) 다음, 고정액으로 세척하고(원심분리→ 상층액 제거→재부유, 3회), 마지막 원심분리 후 적정농도가 되도록 고정액을 남겨 세포 부유 슬라이드위에 점적(최대한 확산하도록)시키고나서, 공기중에서 건조시킨다.Then, centrifuged (1500 rpm, 2 minutes), and then washed with a fixed solution (centrifugation → supernatant removal → resuspension, 3 times), leaving a fixed solution to a titration concentration after the last centrifugation and dropping onto a cell suspension slide ( Spread as much as possible, then dry in air.

그리고 Giemsa 용액내에서 15분간 염색시킨 다음, 증류수를 이용하여 여분의 염색액을 슬라이드에서 제거한다.After dyeing for 15 minutes in Giemsa solution, the excess dye solution is removed from the slide using distilled water.

그 후, 저배율(4×10)에서 고배율(10×40)로 관찰한다.Then, it observes with high magnification (10x40) at low magnification (4x10).

실시예 2 : 이종간(야생동물) 핵이식Example 2 Internuclear (Wildlife) Nuclear Transplantation

제1단계 : 체외성숙(In vitro maturation)Stage 1: In vitro maturation

체외성숙(In vitro maturation)을 위한 배지(Medium)는 다음과 같이 준비하였다.Medium for in vitro maturation was prepared as follows.

배양(culture)용 TCM199(No. 3); 세척(washing)용-TCM199(No. 2);Culture TCM199 (No. 3); For washing-TCM199 (No. 2);

혈청(FBS, 1ml씩 분주되어 있는 것); E2(No. 7); FSH(No. 7)Serum (FBS, dispensed in 1 ml portions); E 2 (No. 7); FSH (No. 7)

상기 배양액을 준비하여 4-웰(well) 디쉬(dish)에 0.5㎕ E2을 분주하고, 알코올을 휘발시킨다. 12.5㎕ FSH(NO.7)을 분주하고 FBS 1㎖를 배양용 TCM199 9㎖에 첨가한 후 각각의 웰에 0.45mL씩 분주한다. 스퀴즈 보틀(Bottle)을 이용하여 웰 사이에 증류수를 분주한다. 35mm 디쉬에 남은 TCM 199 2.5ml를 분주하여 최종 세척액으로 사용한다.Prepare the culture solution and dispense 0.5 μl E 2 into a 4-well dish and volatilize the alcohol. Dispense 12.5 μl FSH (NO.7), add 1 mL of FBS to 9 mL of TCM199 for culture, and dispense 0.45 mL into each well. Distilled water is dispensed between the wells using a squeeze bottle. Dispense 2.5 ml of TCM 199 remaining in a 35 mm dish to use as a final wash.

난소채취는 생리식염수(35℃)와 가위, RP장갑, 장화등을 준비하여 도축장에서 난소를 채취한다.Ovarian collection is prepared by physiological saline (35 ℃), scissors, RP gloves, boots, etc. to collect the ovaries from the slaughterhouse.

검란준비를 위하여는 1cm 간격의 격자 눈금을 그은 100mm 디쉬와 세척용 TCM199을 2ml씩을 분주한 35mm 디쉬를 준비한다. 채취한 난소로부터 18G 니들(needle)이 장착된 10ml 주사기를 사용하여 2∼6mm의 난포를 흡입한다.To prepare the eggs, prepare a 100mm dish with grid scales of 1cm intervals and a 35mm dish dispensed with 2ml of TCM199 for washing. A 2-6 mm follicle is aspirated from the collected ovary using a 10 ml syringe equipped with an 18G needle.

다음에, 검란 및 세정을 수행한다. 먼저 난구세포가 충분히 부착되어 있고 세포질이 균질한 난자를 선발하고, 선발한 난자는 3회의 세정을 거쳐 최종 배양용 TCM199에 골라 놓고 각 웰 당 20∼50개의 난자를 35㎕씩 뽑아 분주한다.Next, the egg and washing are performed. First, eggs that are sufficiently adherent and have a homogeneous cytoplasm are selected, and the selected eggs are washed three times, selected in the final culture TCM199, and 35 μl of 20-50 eggs per each well are dispensed.

체외성숙을 수행함에 있어서는 5% CO2배양기내에서 24시간 배양한다.In vitro maturation is carried out in a 5% CO 2 incubator for 24 hours.

제2단계 : 난구세포 제거(Denuding)Second Step: Denuding

준비물(Preparation)은 다음과 같았다; 세정용 피펫, 제거용 피펫, 하이알루로니데이즈, TCM-W 작업용 미소적Preparation was as follows; Cleaning pipettes, removal pipettes, hyaluronates, micro-manufactured for TCM-W

작업과정(Procedure)은 다음과 같았다.The procedure was as follows.

IVM 16∼22시간의 난자를 세정용 마우스 피펫을 이용하여 TCM-W에 1회 세정한다.IVM 16-22 hours eggs are washed once with TCM-W using a cleaning mouse pipette.

하이알루로니데이즈(No. B-③)용액내에 난자를 분주한다.Dispense the egg into the Hyaluronidase solution (No. B-③).

제거용 피펫으로 난구세포를 벗긴다. TCM-W에 3회정도 세정하고 정치시킨다. 상기 작업은 신속하게 수행하는 것이 바람직하다.Peel the oocytes with a removal pipette. Wash and let stand 3 times in TCM-W. It is desirable to perform the work quickly.

제3단계 : 절개 및 탈핵Step 3: Incision and Denuclearization

준비물(Preparation)은 다음과 같았다.Preparation was as follows.

작업용 디쉬(No. C), 작업용 미소적 - 사이토칼라신 B(Cytochalasin B), 피펫 : 고정용 피펫, 절개 및 탈핵용(cutting & Enucleation) 피펫Working dishes (No. C), working micro-cytochalasin B, pipettes: fixation pipettes, cutting & enucleation pipettes

절개 및 탈핵과정(Procedure)은 다음과 같았다.Incision and denucleation process were as follows.

작업용 디쉬를 조작판(manipulator plate)위에 위치하도록 놓는 다음, 피펫을 장착한다.Place the working dish on the manipulator plate and fit the pipette.

조작장치(Manipulator)의 왼쪽 암(arm)에 고정용 피펫을 장착한 후 조작장치의 오른쪽 암(arm)에 절개용 피펫을 장착한다.After the fixing pipette is mounted on the left arm of the manipulator, the incision pipette is mounted on the right arm of the manipulator.

피펫의 방향 및 위치를 예컨대 다음과 같이 조정한다.The direction and position of the pipette is adjusted, for example, as follows.

즉, 고정용 피펫은 9시 방향에 위치시키고 절개용 피펫은 3시 방향에 위치시킨다. 피펫 조정기를 중립에 놓아 피펫이 상하 좌우로 자유롭게 움직일 수 있도록 조정한다. 두 피펫을 작업용 점적내로 상하 유동시키면서 피펫이 디쉬의 테두리에 닿지 않도록 각도를 조정하고 피펫 끝이 미소적의 중앙에 위치시킨다.That is, the fixing pipette is positioned at 9 o'clock and the cutting pipette is positioned at 3 o'clock. Place the pipette adjuster in neutral to adjust the pipette to move freely up, down, left and right. With both pipettes flowing up and down into the working drop, angle the pipette so that it does not touch the edge of the dish and the pipette tip is centered in the micro drop.

세정용 마우스 피펫(내경 200㎛이상)을 이용하여 TCM-W에 있던 난자(oocyte) 10∼30개 정도를 1개 군으로 하여 절개 및 탈핵 후 점적으로 이동시킨다.About 10-30 oocytes in TCM-W were grouped into one group using a cleaning mouse pipette (more than 200 µm in diameter) and then moved dropwise after incision and denucleation.

다음 방식으로 절개를 실시하였다:The incision was made in the following manner:

즉, 조동나사와 미동나사를 이용하여 난자(oocyte)에 먼저 초점을 맞춘 뒤, 2개의 피펫을 상하로 움직여 초점을 조정한다. 2개의 피펫을 움직여서 파지용 피펫의 12시 방향에 제 1극체(The first polar body)가 위치하도록 한다. 파지용 피펫을 난자(oocyte)의 9시 방향에 밀착시킨 뒤 유압을 걸어 난자(oocyte)를 고정시킨다. 절개 피펫을 1시 방향에서 찔러서 투명대를 통과시킨 뒤 세포질이 다치지 않도록 주의하며 11시 방향으로 관통시킨다. 파지용 피펫에 양압을 걸어 난자를 분리하고 파지용 피펫을 절개 피펫이 통과한 제 1극체 상단부의 투명대에 접촉시키고 두 피펫을 마찰하여 투명대를 절개한다.That is, focusing on oocytes first using coarse and fine screws, and then moving the two pipettes up and down to adjust the focus. The first polar body is positioned at 12 o'clock of the gripping pipette by moving the two pipettes. The phage pipette is in close contact with the oocyte at 9 o'clock and hydraulically fixed to the oocyte. Puncture the incision pipette at 1 o'clock, and pass through the zona pellucida. Positive pressure is applied to the gripping pipette to separate the oocytes, and the gripping pipette is contacted with the transparent zone of the upper end of the first polar body passing through the incision pipette, and the two pipettes are rubbed to cut the transparent zone.

탈핵(Enucleation; Squeezing method)은 다음과 같이 수행하였다.Denucleation was performed as follows.

절개한 난자를 회전시켜 절개창을 수직으로 위치시킨 후 고정용 피펫을 난자의 밑 부위에 위치시켜 난자가 아래쪽으로 움직이지 못하도록 받친 뒤 절개 피펫을 난자의 위에서 눌러 제 1극체를 포함하여 세포질을 10∼30% 탈핵을 실시한다.Rotate the injured egg to position the incision vertically and place the fixation pipette at the bottom of the egg to prevent the egg from moving downward. Then, press the incision pipette on the egg and press down the cytoplasm, including the first polar body. 30% denuclearization.

또는 난자의 절개창을 3시방향에서 수직으로 회전시킨 후 고정용 피펫과 절개 피펫을 아래 위에서 눌러서 제 1극체를 포함하여 세포질의 10∼30% 탈핵을 실시한다. 탈핵시킨 1군의 난자는 TCM-W로 3회 세정하고 핵이식 전까지 IVM용 TCM 199(B-①)에 정치시킨다. 탈핵 후의 난자는 매우 취약하기 때문에 마우스 피펫은 최소한 내경이 300㎛이상 되는 것을 사용하여 작업후 난자의 세포질이 절개창을 통해 빠져 나오지 않도록 주의한다.Alternatively, the incision of the egg is rotated vertically in the 3 o'clock direction, and then the fixation pipette and the incision pipette are pressed down from above to perform 10-30% denucleation of the cytoplasm including the first polar body. The denuclearized group 1 eggs were washed three times with TCM-W and allowed to stand in TCM 199 (B-①) for IVM until nuclear transfer. Since the egg after denuclearization is very fragile, use a mouse pipette with an inner diameter of at least 300 µm to ensure that the cytoplasm of the egg does not escape through the incision after the operation.

제4단계 : 공여핵원용 단일 세포의 분리Step 4: Isolation of Single Cells for Donor Nuclei

페트리 디쉬내의 배양액을 버리고 상기 실험예 1의 0.25% 트립신, 1mM EDTA 용액을 첨가하여 1∼2분 정치시킨후, 1% FCS 첨가 PBS(-)(GIBCO BRL, Life Technologies, USA)에 피펫팅에 의해 재부유시키고, 세포의 수가 적당량이 되도록 조절하여 (2,000/0.1ml) Eppendorf 시험관에 분주시켰다.Discard the culture solution in Petri dishes and let stand for 1 to 2 minutes by adding 0.25% trypsin, 1 mM EDTA solution of Experimental Example 1, pipetting in PBS (-) (GIBCO BRL, Life Technologies, USA) with 1% FCS The cells were resuspended and adjusted to an appropriate number of cells (2,000 / 0.1 ml) and dispensed into Eppendorf tubes.

제5단계 : 공여세포 이식(Injection)Step 5: Injection of Donor Cells

준비물(Preparation)은 다음과 같았다; 작업용 디쉬, 작업용 점적 만들기-PAH, 피펫 : 고정용 피펫, 주사용 피펫, 공여 세포 미소적(Donor 세포 준비 참조)Preparation was as follows; Working dish, working drop making-PAH, pipette: fixation pipette, injection pipette, donor cell micro (see Donor cell preparation)

작업과정(Procedure)은 다음과 같았다.The procedure was as follows.

작업용 디쉬를 조작판(manipulator plate)에 위치시킨다.Place the working dish on the manipulator plate.

절개 피펫을 주사용 피펫으로 교체시킨다.The incision pipette is replaced with an injection pipette.

IVM 배지내에 있는 난자(oocyte)를 세정용 마우스 피펫을 이용하여 TCM-W 점적에서 1∼3회 세정후 주입용 미소적으로 이동시킨다.Oocytes in IVM medium are transferred microscopically for injection after one to three washes in a TCM-W drop using a cleaning mouse pipette.

이식용(Injection) 피펫을 공여세포 미소적에 넣고 20∼40㎛크기의 1개 이상의 공여세포를 흡입한 뒤 피펫을 주입용 미소적으로 이동시킨다.Insert the injection pipette into the donor cell microparticles, inhale one or more donor cells of 20-40 μm in size, and then move the pipette microscopically for injection.

절개창을 양 피펫과 1시방향에 수직으로 놓고 고정용 피펫으로 고정한다.Place the incision perpendicular to both pipettes and the 1 o'clock position and secure with a fixed pipette.

이식용(Injection) 피펫을 절개창으로 주입하고, 유압을 걸어 1개의 공여세포을 주입시킨다.An injection pipette is injected into the incision and hydraulically infused one donor cell.

작성된 핵이식란 군을 마우스 피펫으로 세정용 미소적으로 옮겨 1∼3회 세정하고 정치시킨다.The resulting nuclear transfer egg group is transferred to a washing microscopically with a mouse pipette, and then washed and left to set once or three times.

실시예 4 : 세포융합(Cell Fusion)Example 4 Cell Fusion

세포융합에 필요한 준비물(Preparation)은 다음과 같았다; 기기-BTX ECM 2001Preparations for cell fusion were as follows; Instrument-BTX ECM 2001

만니톨(Manitol)을 4-웰 디쉬의 3개의 웰(1번, 2번, 3번 웰, 순서는 상관없음)에 0.4ml∼1ml 분주하고, 나머지 1개의 웰 (4번)에는 10% TCM-W가 첨가된 만니톨을 제조한다.Manitol is dispensed from 0.4 ml to 1 ml into three wells of 4-well dishes (wells 1, 2 and 3, in any order) and 10% TCM- for the other well (4). Prepare mannitol to which W is added.

만일 융합과 활성화를 동시에 실시할 경우는 Ca2+첨가 융합배지를 사용하며, 융합후 활성화군에서는 Ca2+를 배제한 융합배지를 사용한다.If fusion and activation are performed at the same time, Ca 2+ -added fusion medium is used, and in the activation group after fusion, Ca 2+ fusion medium is used.

다음, 2개 전극(3.2mm chamber No. 453)에 만니톨을 0.2∼1ml 넣고 BTX-세포 조작기와 연결시킨다.Next, 0.2-1 ml of mannitol is placed in two electrodes (3.2 mm chamber No. 453) and connected to a BTX-cell manipulator.

이때, 세포융합 조건은 다음과 같았다.At this time, the cell fusion conditions were as follows.

DC 조건 : 전압(Voltage)은 0,75∼2.25kv/cm이며, 횟수(Times)는 1∼2회, 시간(Seconds)은 회수×시간 총 60㎲ 이내로 조정한다.DC condition: Voltage is 0,75 ~ 2.25kv / cm, Times is 1 ~ 2 times, and Seconds is adjusted within 60ms of recovery time × time.

작업과정(Procedure)은 다음과 같았다.The procedure was as follows.

작업 1시간전 BTX를 가동하여 예열한 다음 세정용 마우스 피펫에 10∼20㎕의 만니톨을 빨아들인 후 핵이식란이 있는 TCM-W 미소적에 첨가한다.One hour prior to operation, the BTX was run and preheated, and 10-20 μl of mannitol was sucked into the cleaning mouse pipette and added to the microtransplanted TCM-W microspheres.

1분 이상 정치시킨 후 세정용 마우스 피펫을 이용하여 4번 웰(10% TCM-W 만니톨)에 핵이식란을 주입한다.After standing for at least 1 minute, a nuclear transfer egg is injected into well 4 (10% TCM-W mannitol) using a cleaning mouse pipette.

1분 이상 정치시킨 후 세정용 마우스 피펫을 이용하여 1번 웰에 넣고, 같은 방법으로 2번 웰에 핵이식란을 이동시킨다.After standing for 1 minute or more, the wells are placed in the well 1 using a cleaning mouse pipette, and the nuclear transfer egg is transferred to the second well in the same manner.

마우스 피펫을 이용하여 핵이식란을 하나씩 2개 전극 사이에 놓고 공여세포가 (+)전극을 향하도록 정렬시킨다.Using a mouse pipette, the nuclear transfer eggs are placed between two electrodes one by one and aligned so that donor cells face the positive electrode.

통전을 실시하고 융합한 핵이식란은 3번 웰에 모아서 1개 군의 융합이 끝나면 TCM-W로 옮겨 3회 세정한다.The energized and fused nuclear transfer embryos are collected in three wells and transferred to TCM-W for cleaning three times after the fusion of one group is completed.

Cytochalasin B 미소적내에서 30∼60분간 처리후, 융합·활성을 동시에 실시하게 될 군은 후활성화(postactivation) 과정으로, 융합 후에 활성화시킬 군은 상기의 화학물질을 이용하여 활성화시킨다.After treatment for 30 to 60 minutes in the cytochalasin B microsphere, the group that will perform the fusion and activity at the same time is a postactivation process, and the group to be activated after the fusion is activated using the above chemicals.

활성화(Activation)는 다음과 같이 실시하였다.Activation was performed as follows.

융합과 동시에 일렉트로퓨젼(elecrofusion) 방법으로 활성화를 유도하는 경우에는 Ca2+첨가 융합배지내에서 일렉트로퓨젼(electrofusion)을 실시한다.In the case of induction of activation by the electrofusion method at the same time as the fusion, electrofusion is performed in a Ca 2+ -added fusion medium.

Ionomycin(B-⑨)처리법으로 활성화를 유도하는 경우에는, B-⑨, 50㎕ 점적내에서 4분간 정치(빛에 민감하므로 되도록 빛의 유입을 차단)하고, 35mm 디쉬내 10% FBS 혹은 30mg/ml BSA 첨가하고 세정용 매질하에서 이노마이신 (Ionomycin)을 제거한 뒤 5분간 정치시킨다.In the case of induction of activation by the ionomycin (B-⑨) treatment, B-⑨, incubated for 4 minutes in a 50 µl drop (it is sensitive to the light, blocking the inflow of light as much as possible), and 10% FBS or 30 mg / in 35 mm dish. ml BSA is added and the inomycin is removed under washing medium and left to stand for 5 minutes.

실시예 5 : 융합 후 활성화(Postactivation)Example 5 Postactivation

Cycloheximide 25㎕ 미소적 내에 5∼10개 정도의 작성란을 침지하여 6시간 배양하였고, DMAP 25㎕ 미소적 내에 5∼10개 정도의 작성란을 침지하여 4시간 배양시켰다.About 5-10 eggs were immersed in 25 µl of cyclocloximide for 6 hours, and 5-10 cells were immersed in 25 µl of DMAP for 4 hours.

배양은 다음과 같이 수행하였다.Cultivation was performed as follows.

상기 실시예 1 제2단계의 배양액(Culture medium) 중 택일하여 5% CO2배양기 또는 5% CO2, 7% O2, 88% N2에서 5∼8일간 배양한다. 활성화(Activation) 후 24시간 전후로 검란, 발육단계별로 구분하여 미소적내에 배치한다.Example 1 The culture medium (Culture medium) of the second step is alternatively incubated for 5 to 8 days in a 5% CO 2 incubator or 5% CO 2 , 7% O 2 , 88% N 2 . After about 24 hours after activation (Activation), it is arranged within the microscopic division by egg phase and development stage.

매일 아침, 저녁으로 검란하여 이후 발육을 관찰한다.Every morning and evening, the gumran to observe the subsequent development.

이상과 같이, 수핵란으로는 소의 난자를 이용하고 야생동물인 호랑이의 여러 조직으로부터 세포주를 분리보존하고, 최초 세포의 세포막의 일부를 절개하고 세포질의 10 내지 30%의 탈핵을 실시한 다음, 상기 공여세포를 상기 핵이 탈핵된 난자에 이식하여 전기융합시키고 활성화 및 후활성화 단계 후, 배양 및 성숙시킴으로써, 야생동물 보존의 일환으로 체세포의 복제에 의해 임신가능한 호랑이의 수정란을 생산할 수 있게 된다.As described above, using a bovine egg as a nucleated egg, isolating and preserving a cell line from various tissues of a tiger which is a wild animal, dissecting a part of the cell membrane of the first cell and denuclearizing 10-30% of the cytoplasm, and then the donor cells By implanting the nucleus into the denuclearized egg and electrofusion, and after the activation and post-activation step, by culturing and maturation, it is possible to produce fertilized tiger embryos capable of replicating somatic cells as part of wildlife conservation.

이하에서는 전술한 본 발명의 각각의 공정에 사용되는 다양한 배지들의 종류와 그 조성을 표 1과 표 2에 제시하였고 표 3에는 호랑이 복제 수정란 작성 이후 발육을 나타냈다.Hereinafter, the types and compositions of the various media used in each of the above-described processes of the present invention are shown in Tables 1 and 2, and Table 3 shows the development after creation of tiger cloned fertilized eggs.

본 발명에서 생산한 8세포기의 수정란은Bos taurus coreanaeembryos/TcEar로 명명하고 2000년 1월 7일 생명공학연구소 미생물기탁센터에 KCTC 0719BP로 기탁하였다.The 8- cell fertilized egg produced in the present invention was named Bos taurus coreanae embryos / TcEar and was deposited as KCTC 0719BP at the Biotechnology Research Institute of Biotechnology on January 7, 2000.

TCM-Culture mediumTCM-Culture medium 성 분ingredient 농 도Concentration TCM liquidNa-pyruvateP/STCM liquidNa-pyruvateP / S Gibco 11150-0591mM1% (Penicilin 10000IU, Streptomycin 10mg)Gibco 11150-0591mM1% (Penicilin 10000IU, Streptomycin 10mg)

CR2aa mediumCR2aa medium 성 분ingredient Develope IDevelope I Develope IIDevelope II CR-WashCR-Wash NaClo NaCl o 114mM114mM 114mM114mM 114mM114mM KClo KCl o 3.1mM3.1mM 3.1mM3.1mM 3.1mM3.1mM NaHCO3 O NaHCO 3 O 25mM25mM 25mM25mM 2mM2 mM NaH2PO4 NaH 2 PO 4 0.35mM0.35mM 0.35mM0.35mM 0.34mM0.34mM Sod.Lactater Sod.Lactate r 15mM15 mM 15mM15 mM 15mM15 mM CaCl2·2H2Od CaCl 2 · 2H 2 O d 2mM2 mM -- 2mM2 mM MgCl2·6H2Od MgCl 2 · 6H 2 O d 0.5mM0.5mM 0.5mM0.5mM 0.5mM0.5mM EAAEAA -- 1%One% -- NEAANEAA 1%One% 1%One% 1%One% InsulinInsulin 1%One% 1%One% 1%One% GlutamineGlutamine -- 1mM1 mM 1One GlycineGlycine 0.37mM0.37mM 0.37mM0.37mM 0.37mM0.37mM CitrateCitrate 0.33mM0.33mM 0.33mM0.33mM 0.33mM0.33mM HEPESHEPES -- -- 10.5mM10.5mM Na-pyruvateNa-pyruvate 0.3mM0.3mM 0.3mM0.3mM -- GlucoseGlucose -- 1.5mM1.5mM -- Phenol-RedPhenol-red 10㎍/ℓ10 μg / ℓ 10㎍/ℓ10 μg / ℓ 10㎍/ℓ10 μg / ℓ BSABSA 3㎎/㎖3mg / ml -- 3/㎖3 / ml FCSFCS -- 10%10% -- KanamycinKanamycin 0.75㎍/㎖0.75 µg / ml 0.75㎍/㎖0.75 µg / ml 0.75㎍/㎖0.75 µg / ml

호랑이 복제 수정란작성 이후 발육Development after tiger cloning fertilization 융합난자수Number of fused eggs 융합률(%)% Convergence 분할률(%)% Split 2cell2cell 4∼7cell4 to 7cell 8cell8cell 배반포 개수Number of blastocysts 272272 139(51)139 (51) 96(73)96 (73) 2020 1919 2323 00

상기 실시예와 실험예를 통하여 확인할 수 있는 바와 같이, 본 발명에 의해 야생동물의 보전의 한 방법으로 핵이식을 이용하여 야생동물의 복제수정란 생산이가능하게 됨에 따라, 장차 축산학 및 의약학 분야에서 복제동물 및 이를 이용한 약제 또는 장기 등의 대량 생산 효과가 있다. 또한, 본 발명에 따라 복제 동물을 생산하고 그와 관련된 응용분야가 개척될 수 있는 가능성이 있어 본 발명은 축산학, 의약학 및 동물복제산업상 매우 유용한 발명이다.As can be seen from the above examples and experimental examples, according to the present invention, as a method of preservation of wild animals, it is possible to produce cloned fertilized eggs of wild animals using nuclear transplantation, which will be reproduced in the field of animal husbandry and medicine in the future. There is an effect of mass production of animals and drugs or organs using the same. In addition, there is the possibility of producing cloned animals according to the present invention and pioneering applications related thereto, and thus the present invention is a very useful invention in animal husbandry, medicine and animal cloning industry.

Claims (3)

호랑이의 복제수정란 생산방법에 있어서,In the production method of cloned fertilized eggs of tiger, (a) 도축난소로부터 미성숙난자를 채취·배양하는 단계;(a) harvesting and culturing immature eggs from slaughterhouses; (b) 호랑이의 신체의 다양한 조직으로부터 세포주를 분리하여 보존하는 단계;(b) separating and conserving cell lines from various tissues of the tiger's body; (c) 상기 (a)단계에서 준비된 성숙난자의 투명대 일부를 절개하고 제 1극체와 함께 세포질의 10 내지 30%를 제거하여 탈핵을 실시하는 단계;(c) dissecting a portion of the zona pellucida of the mature egg prepared in step (a) and denuclearizing by removing 10-30% of the cytoplasm with the first polar body; (d) 상기 (b)단계에서 준비된 공여세포를 상기 (c)단계의 탈핵된 난자에 이식하는 단계;(d) transplanting the donor cells prepared in step (b) into denucleated eggs of step (c); (e) 상기 (d)단계에서 이식 및 밀착시킨 작성란을 DC 조건의 전압으로 전기융합시키는 단계;(e) electrically fusion of the embryonated eggs implanted and adhered in step (d) to a voltage under DC conditions; (f) 상기 융합된 세포를 융합과 동시에 또는 화학물질이 첨가된 배지내에서 활성화시키는 단계; 및(f) activating the fused cells concurrently with fusion or in a medium to which chemicals have been added; And (g) 상기 활성화된 세포를 후활성화 및 미소적 배지내에서 배양한 후 검란하는 단계를 포함하는 것을 특징으로 하는 복제수정란의 생산 방법(g) a method for producing cloned fertilized eggs, comprising activating the activated cells and culturing them in post-activation and micro medium. 제1항에 있어서, 상기 (b)단계의 세포주가 호랑이 귀로부터 분리된 세포주임을 특징으로 하는 복제수정란의 생산 방법The method of claim 1, wherein the cell line of step (b) is a cell line isolated from tiger ears. 제 1 항 또는 제 2 항에 의해 생산된 호랑이의 복제수정란Bos taurus coreanaeembryos/TcEar(KCTC 0719BP).Cloning fertilization of tiger produced according to claim 1 or 2 Bos taurus coreanae embryos / TcEar (KCTC 0719BP).
KR1020000004381A 1999-06-30 2000-01-28 Embryo from wild animal with inter-species nuclear transplantation and method for production thereof KR20010069167A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020000004381A KR20010069167A (en) 1999-08-30 2000-01-28 Embryo from wild animal with inter-species nuclear transplantation and method for production thereof
EP00941006A EP1117763A4 (en) 1999-06-30 2000-06-30 Method for producing cloned tigers by employing inter-species nuclear transplantation technique
JP2001506788A JP2003503045A (en) 1999-06-30 2000-06-30 Clonal tiger production method using xenogeneic nuclear transfer technology
RU2000132214/13A RU2205537C2 (en) 1999-06-30 2000-06-30 Method for obtaining cloned tiger due to applying method of interspecific nuclear transplantation
PCT/KR2000/000706 WO2001000794A1 (en) 1999-06-30 2000-06-30 Method for producing cloned tigers by employing inter-species nuclear transplantation technique
CN 00800651 CN1304445A (en) 1999-06-30 2000-06-30 Method for producing cloned tigers by employing inter-species nuclear transplantation technique
NZ508739A NZ508739A (en) 1999-06-30 2000-06-30 Method for producing cloned tigers by employing inter-species nuclear transplantation technique
CA002334954A CA2334954A1 (en) 1999-06-30 2000-06-30 A method for producing cloned tigers by employing inter-species nuclear transplantation technique
AU55777/00A AU753209B2 (en) 1999-06-30 2000-06-30 Method for producing cloned tigers by employing inter-species nuclear transplantation technique

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19990036373 1999-08-30
KR1019990036373 1999-08-30
KR1020000004381A KR20010069167A (en) 1999-08-30 2000-01-28 Embryo from wild animal with inter-species nuclear transplantation and method for production thereof

Publications (1)

Publication Number Publication Date
KR20010069167A true KR20010069167A (en) 2001-07-23

Family

ID=26636084

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020000004381A KR20010069167A (en) 1999-06-30 2000-01-28 Embryo from wild animal with inter-species nuclear transplantation and method for production thereof

Country Status (1)

Country Link
KR (1) KR20010069167A (en)

Similar Documents

Publication Publication Date Title
Kątska-Książkiewicz et al. Effects of oocyte quality, semen donor and embryo co-culture system on the efficiency of blastocyst production in goats
JP2008017840A (en) Growth of embryonic stem cell
WO2007100845A2 (en) Non-embryonic totipotent blastomere-like stem cells and methods therefor
CN113025565B (en) Establishment of salmon sperm primitive stem cell line and induced differentiation method thereof
KR20060032953A (en) Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
CN107227298A (en) A kind of clone embryos treatment fluid and its application method and the purposes of the treatment fluid
KR100342437B1 (en) Method for enucleation of oocyte for producing a clone animal using somatic cell
Han et al. Isolation and characterization of chicken primordial germ cells and their application in transgenesis
Hamra et al. Isolating highly pure rat spermatogonial stem cells in culture
Aghaz et al. Enhanced in vitro developmental competence of sheep embryos following sericin supplementation of the in vitro maturation and in vitro culture media
CN104513807A (en) Method for separating cells from blood and cultivating the cells and method for cloning non-human animal
Pinto et al. Specific induction of self‐discrimination by follicle cells in Ciona intestinalis oocytes
KR100368435B1 (en) Method of cell fusion for producing a clone animal using somatic cell
KR100414043B1 (en) Clone animal reproduced from somatic cell and method for production thereof
KR20010076941A (en) Embryo from wild animal with inter-species nuclear transplantation and method for production thereof
KR100342438B1 (en) Method for activation of fused cell for producing a clone animal using somatic cell
KR20010069167A (en) Embryo from wild animal with inter-species nuclear transplantation and method for production thereof
KR20010069217A (en) Method for production of stem cell from human with inter-species nuclear transplatation
KR20010005426A (en) Clone animal reproduced from somatic cell and method for production thereof
JP2003052369A (en) Method for collecting m-stage or g1-stage cell and method for transplanting nucleus using the cell
KR100767289B1 (en) Embryonic stem cell culture method
KR20080077738A (en) A methods to improve in vitro maturation of pig oocytes
Korfiatis et al. Cell synchronization for the purposes of nuclear transfer in the bovine
KR100427217B1 (en) Cell fusion method and enucleation method of the cytoplast for the production of somatic animal clon
CN112852711B (en) Establishment and application of coilia ectenes gonad somatic cell line

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application